BioSpace News Archive

Biotech Beach

Cardiff Oncology to Participate in a Fireside Chat at the William Blair Biotech Focus Conference 2021

Cardiff Oncology, Inc. today announced that Dr. Mark Erlander , chief executive officer of Cardiff Oncology, will participate in a fireside chat and virtual 1x1 investor meetings at the William Blair Biotech Focus Conference 2021 taking place virtually from July 14-15, 2021.

July 6, 2021
·
2 min read
Business

Locanabio Expands Leadership Team with Appointment of Chief Scientific Officer and Chief Medical Officer

Locanabio, Inc. today announced the appointment of John P. Leonard , PhD, to chief scientific officer and Edward R. Conner , MD, to chief medical officer, effective today.

July 6, 2021
·
4 min read
Business

Novavax to Host Conference Call to Discuss Second Quarter Financial Results and Operational Highlights on August 5, 2021

Novavax, Inc. today announced it will report its second quarter 2021 financial results and operational highlights on Thursday, August 5, 2021 , following the close of U.S. financial markets.

July 6, 2021
·
2 min read
Business

Diality Poised to Revolutionize Dialysis Treatment - In Development of Versatile Home Dialysis System; Welcomes Industry Veteran Dan Guthrie as Chief Business Officer

Medical device startup Diality announced Dan Guthrie would become the newest member of its executive team, serving as Chief Business Officer effective July 1 .

July 6, 2021
·
3 min read
Biotech Beach

Biocept Receives South Korean Patent for Primer-Switch Platform Used to Identify Rare Genetic Mutations, Including Cancer Biomarkers

Biocept, Inc . (NASDAQ: BIOC), a leading provider of molecular diagnostic assays and services, has been awarded a South Korean Patent for its Primer-Switch technology.

July 6, 2021
·
4 min read
Biotech Bay

Avinger Announces 510(k) Filing for New Pantheris In-Stent Restenosis Indication

Avinger, Inc. today announced the submission of a 510(k) application to the U.S. Food & Drug Administration (FDA) for a new Pantheris clinical indication for the treatment of in-stent restenosis (ISR) in the lower extremity arteries.

July 6, 2021
·
6 min read
Viveve to Participate in Ladenburg Thalmann Healthcare Virtual Conference

Viveve Medical, Inc. today announced that Scott Durbin, chief executive officer, will participate in the Ladenburg Thalmann Healthcare Conference, July 13 - 14, 2021.

July 6, 2021
·
4 min read
Pharm Country

Y-mAbs Announces NMPA Submission of BLA for DANYELZA® (naxitamab-gqgk) in China

Y-mAbs Therapeutics, Inc. today announced that SciClone Pharmaceuticals (Holdings) Limited (“SciClone Pharmaceuticals”) has submitted the Biologics License Application (“BLA”) for DANYELZA® (naxitamab-gqgk) for the treatment of patients with relapsed/refractory neuroblastoma.

July 6, 2021
·
5 min read
Business

Extendicare Announces Timing of 2021 Second Quarter Results and Conference Call

Extendicare Inc. announced that it plans to release its financial results for the second quarter of 2021 after market close on Thursday, August 5, 2021.

July 6, 2021
·
1 min read
Business

ImmixBio Announces Gabriel Morris as Chief Financial Officer and a Member of the Board of Directors

Immix Biopharma, Inc. today announced that Gabriel Morris has joined its leadership team as Chief Financial Officer and a member of the Board of Directors.

July 6, 2021
·
2 min read